Literature DB >> 12297837

The significance of human jagged 1 mutations detected in severe cases of extrahepatic biliary atresia.

Takao Kohsaka1, Zeng-Rong Yuan, Shu-Xia Guo, Manabu Tagawa, Akio Nakamura, Miwako Nakano, Hideo Kawasasaki, Yukihiro Inomata, Koichi Tanaka, Jun Miyauchi.   

Abstract

Mutations of human jagged 1 (JAG1) gene are responsible for Alagille Syndrome (AGS), whose 2 main symptoms are intrahepatic bile duct hypoplasia and pulmonary stenosis. We examined the JAG1 mutation in extrahepatic biliary atresia (EHBA), which is similar in phenotype to AGS, although a different pathogenesis is suggested. In 102 cases of EHBA, 9 missense mutations were detected, including 2 intrafamilial expressions in the propositus and an aunt of one family. These mutations were all missense and sporadic except for those of this particular family. The JAG1 gene mutations were generally found in severely ill patients subjected to liver transplantation at less than 5 years of age. None of the 9 cases of EHBA revealed any of the 5 major symptoms of AGS nor any identical pathological findings after 3 years of follow-up. Our cases were clearly separated from AGS by pathological findings and clinical features, and could be diagnosed as EHBA and not as atypical AGS. The increase of interleukin 8 (IL-8) production induced by tumor necrosis factor alpha (TNF-alpha) in Huh 7 cells was suppressed by the coexistence of JAG1 protein. We examined the different influences between wild-type cells and the 3 kinds of mutants detected in EHBA on Huh 7 cells and found that 2 of 3 mutants showed about half of the repressed activity compared with that of wild type. In conclusion, these results suggest that the JAG1 gene abnormality may be an aggravating factor in EHBA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297837     DOI: 10.1053/jhep.2002.35820

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  30 in total

1.  Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis.

Authors:  Robert C Bauer; Ayanna O Laney; Rosemarie Smith; Jennifer Gerfen; Jennifer J D Morrissette; Stacy Woyciechowski; Jennifer Garbarini; Kathleen M Loomes; Ian D Krantz; Zsolt Urban; Bruce D Gelb; Elizabeth Goldmuntz; Nancy B Spinner
Journal:  Hum Mutat       Date:  2010-05       Impact factor: 4.878

Review 2.  Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes.

Authors:  Akihiro Asai; Alexander Miethke; Jorge A Bezerra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-26       Impact factor: 46.802

3.  Sox17 haploinsufficiency results in perinatal biliary atresia and hepatitis in C57BL/6 background mice.

Authors:  Mami Uemura; Aisa Ozawa; Takumi Nagata; Kaoruko Kurasawa; Naoki Tsunekawa; Ikuo Nobuhisa; Tetsuya Taga; Kenshiro Hara; Akihiko Kudo; Hayato Kawakami; Yukio Saijoh; Masamichi Kurohmaru; Masami Kanai-Azuma; Yoshiakira Kanai
Journal:  Development       Date:  2013-02-01       Impact factor: 6.868

Review 4.  Hepatic phenotypes of HNF1B gene mutations: a case of neonatal cholestasis requiring portoenterostomy and literature review.

Authors:  Radana Kotalova; Petra Dusatkova; Ondrej Cinek; Lenka Dusatkova; Tomas Dedic; Tomas Seeman; Jan Lebl; Stepanka Pruhova
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

5.  Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis.

Authors:  Cong Liu; Bruce J Aronow; Anil G Jegga; Ning Wang; Alex Miethke; Reena Mourya; Jorge A Bezerra
Journal:  Gastroenterology       Date:  2006-10-21       Impact factor: 22.682

6.  Embryonic cholecystitis and defective gallbladder contraction in the Sox17-haploinsufficient mouse model of biliary atresia.

Authors:  Hiroki Higashiyama; Aisa Ozawa; Hiroyuki Sumitomo; Mami Uemura; Ko Fujino; Hitomi Igarashi; Kenya Imaimatsu; Naoki Tsunekawa; Yoshikazu Hirate; Masamichi Kurohmaru; Yukio Saijoh; Masami Kanai-Azuma; Yoshiakira Kanai
Journal:  Development       Date:  2017-04-21       Impact factor: 6.868

7.  Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study.

Authors:  Kathleen B Schwarz; Barbara H Haber; Philip Rosenthal; Cara L Mack; Jeffrey Moore; Kevin Bove; Jorge A Bezerra; Saul J Karpen; Nanda Kerkar; Benjamin L Shneider; Yumirle P Turmelle; Peter F Whitington; Jean P Molleston; Karen F Murray; Vicky L Ng; René Romero; Kasper S Wang; Ronald J Sokol; John C Magee
Journal:  Hepatology       Date:  2013-09-19       Impact factor: 17.425

8.  Evidence from human and zebrafish that GPC1 is a biliary atresia susceptibility gene.

Authors:  Shuang Cui; Melissa Leyva-Vega; Ellen A Tsai; Steven F EauClaire; Joseph T Glessner; Hakon Hakonarson; Marcella Devoto; Barbara A Haber; Nancy B Spinner; Randolph P Matthews
Journal:  Gastroenterology       Date:  2013-01-18       Impact factor: 22.682

9.  Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury.

Authors:  Junquan Xu; Gene Lee; Haimei Wang; John M Vierling; Jacquelyn J Maher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-05-06       Impact factor: 4.052

Review 10.  Biliary atresia.

Authors:  Giorgina Mieli-Vergani; Diego Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.